SCHEMBL18832276

SCHEMBL18832276

CC(C)(C)N(C(=O)OCC1c2ccccc2-c2ccccc21)[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
FABP5 Q01469 3/20 0.40
FABP7 O15540 2/20 0.40
CASP3 P42574 2/20 0.39
MDM4 O15151 2/20 0.38
TP53 P04637 2/20 0.38
PTPN1 P18031 1/20 0.36
EPHX2 P34913 1/20 0.36
SELP P16109 1/20 0.35
TLR2 O60603 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29047040 1.00 KMT2A (0.45) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL29047057 0.92 KMT2A (0.44) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL2247201 0.91 KMT2A (0.43) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL30074272 0.91 KMT2A (0.39) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL8641226 0.89 CASP3 (0.45) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL28863857 0.88 KMT2A (0.44) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL28863858 0.88 KMT2A (0.44) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL2367136 0.87 FABP5 (0.42) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL32675282 0.87 FABP5 (0.42) KMT2AFABP5FABP7CASP3MDM4
SCHEMBL2544051 0.86 FABP5 (0.41) KMT2AFABP5FABP7CASP3MDM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114380880-B Fmoc-amino acid modified 20 (S) -protopanoxadiol derivative and preparation method and application thereof 吉林大学 2023-06-23 CN claimed
CN-114380880-B Fmoc-amino acid modified 20 (S) -protopanoxadiol derivative and preparation method and application thereof 吉林大学 2023-06-23 CN disclosed
EP-3168288-B1 FLUORESCENT PROBE FOR DETECTING DIPEPTIDYL PEPTIDASE IV UNIV TOKYO (JP) 2020-06-03 EP disclosed
US-10383956-B2 Fluorescent probe for detecting dipeptidyl peptidase IV THE UNIVERSITY OF TOKYO (JP) 2019-08-20 US disclosed
US-20170157272-A1 FLUORESCENT PROBE FOR DETECTING DIPEPTIDYL PEPTIDASE IV THE UNIVERSITY OF TOKYO (JP) 2017-06-08 US disclosed
EP-3168288-A1 FLUORESCENT PROBE FOR DETECTING DIPEPTIDYL PEPTIDASE IV The University of Tokyo (JP) 2017-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10383956-B2 Fluorescent probe for detecting dipeptidyl peptidase IV DPP4, DPP7, DPP3 KMT2A 2647/4885FABP5 1518/4885FABP7 2040/4885
US-20170157272-A1 FLUORESCENT PROBE FOR DETECTING DIPEPTIDYL PEPTIDASE IV DPP4, DPP7, DPP3 KMT2A 2722/4885FABP5 1006/4885FABP7 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.